Pancreatic cancer (PC) is one of the most lethal cancers and 12th most common cancer in the world. Due to the inaccessible anatomical position of the
pancreas and asymptomatic early stages of this disease, PC has a high mortality rate. Therefore, providing reliable diagnostic and therapeutic tools are the
keys to increase the PC survival rate. Nanotechnology is an inchoate field of
science that previously scientists' tendency to enhance the efficacy of current
preventive, diagnostic, and therapeutic methods has oriented them to build a
bridge between this science and medicine. In the case of PC, nanotechnology
suggests using drug delivery devices for a more effective and targeted therapy.
Chitosan is a natural polymer that recently has attracted a lot of attention for
being renewable, nontoxic, and bioabsorbable. In this article, we tend to look
for the answer to this question: has nanotechnology been successful in using
chitosan-based nanoformulations as carriers for preventing more individuals
from suffering or at least increasing the 5-year survival of the PC patients